Data protection Impressum

Manufacturing

Siegfried’s Evionnaz site currently employs 380 professionals and is in the process of constructing a new R&D building, which is set to double the company's development capacity and create around 40 new jobs.

Siegfried, a Swiss leader taking innovations to industrial scale for the pharmaceutical industry

4 December 2023

Located in Lonza's Visp industry park, Bacthera's MC4a Center of Excellence covers 12,000 square meters, featuring three manufacturing floors with one dedicated to SER-109 production.

Bacthera’s Visp plant aims to revolutionize microbiome-based treatments

30 October 2023

CDMOs play a crucial role in the pharmaceutical sector, serving as key partners in the drug development and production process.

Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings

16 October 2023

Lonza continues to fortify its position in ADC production, expanding collaboration and infrastructure to enhance its acclaimed Ibex Dedicate Biopark.

Lonza further extends its ADC manufacturing capabilities in Visp

9 October 2023

Multiwave is on the verge of FDA approval for MGNTQÔ, its device described as the world's lightest portable MRI scanner.

Multiwave Technologies secures CHF 3.8 million for its light portable MRI device

19 September 2023

This agreement will ease trade of medicines with the United States and reduce the administrative burden for the industry.

Business environment

Switzerland and USA implement mutual recognition agreement to streamline pharmaceutical trade

31 July 2023

Merck unveils its cutting-edge Biotech Development Center in Corsier-sur-Vevey

12 June 2023

Lonza boosts next-generation anticancer drugs with CHF 97 million investment in Visp

7 June 2023

SELFRAG secures CHF 14.3 million to transform waste into valuable products

13 March 2023

Rolex to establish a new production site in Bulle with 2,000 jobs

14 December 2022

1 2 3 4 5